News
Pfizer's 7.45% dividend yield can't offset weak growth, declining EPS, and patent risks. Read more on PFE and why analysts ...
Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and ...
Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...
Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands ...
StockStory.org on MSN1d
PFE Q1 Earnings Call: Revenue Misses, Margin Expansion, and Focus on Pipeline ProductivityGlobal pharmaceutical company Pfizer (NYSE:PFE) in Q1 CY2025, with sales falling 7.8% year on year to $13.72 billion. The ...
Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmaker's exceptionally juicy dividend these ...
Explore more
The executive order that Donald Trump has signed over the last 24 hours could have a significant effect on pharmaceutical ...
Insider Monkey on MSN10d
Is Pfizer Inc. (PFE) The Most Profitable Cheap Stock to Buy Now?We recently compiled a list of the 10 Most Profitable Cheap Stocks to Buy Now. In this article, we are going to take a look ...
We recently published a list of 13 Stock Predictions That Jim Cramer Got Completely Wrong. In this article, we are going to ...
NEW YORK, April 29, 2025--Pfizer Inc. (NYSE: PFE) reported financial results for the first quarter of 2025 and reaffirmed its 2025 financial guidance(1). NEW YORK, April 26, 2025--Pfizer Inc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results